DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 226 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,170,847 | +16.8% | 79,272 | +2.2% | 0.01% | +25.0% |
| Q2 2023 | $1,002,243 | +25.4% | 77,573 | -4.8% | 0.00% | 0.0% |
| Q1 2023 | $799,319 | -9.2% | 81,480 | -1.5% | 0.00% | 0.0% |
| Q4 2022 | $880,024 | +88.0% | 82,709 | +84.5% | 0.00% | +100.0% |
| Q3 2022 | $468,000 | +123.9% | 44,831 | +170.0% | 0.00% | +100.0% |
| Q2 2022 | $209,000 | +2.5% | 16,607 | -11.7% | 0.00% | 0.0% |
| Q1 2022 | $204,000 | -81.7% | 18,818 | -67.5% | 0.00% | -80.0% |
| Q3 2021 | $1,112,000 | +23.6% | 57,885 | -36.6% | 0.01% | +25.0% |
| Q2 2021 | $900,000 | -33.1% | 91,345 | -33.2% | 0.00% | -33.3% |
| Q1 2021 | $1,345,000 | +773.4% | 136,834 | +296.5% | 0.01% | +500.0% |
| Q4 2020 | $154,000 | -7.8% | 34,512 | +215.8% | 0.00% | 0.0% |
| Q2 2018 | $167,000 | -47.3% | 10,929 | -31.5% | 0.00% | -50.0% |
| Q1 2018 | $317,000 | – | 15,958 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
| Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
| Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
| Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
| Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
| Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
| AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
| HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
| Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
| Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |